Irexime

Clindamycin and Benzoyl Peroxide, the active ingredients in Irexime, are a combination antibiotic and keratolytic presented as a topical formulation for skin use. It treats acne vulgaris in adolescents and adults by reducing bacterial growth and follicular blockage.

GNH USA supplies Irexime as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Irexime is a topical combination that targets the bacterial and keratinous components of acne. It is indicated for: - Acne vulgaris: reduces inflammatory lesions and comedones, improving overall skin appearance. - Inflammatory acne: diminishes redness, swelling, and pustule formation. - Non‑inflammatory acne: helps prevent formation of blackheads and whiteheads.

Irexime may cause local skin reactions, most of which are mild and transient.

Common Side Effects: - Dryness: skin feels less hydrated after application. - Redness: mild erythema at the site of use. - Peeling: superficial desquamation of the epidermis. - Itching: occasional pruritus. - Burning sensation: brief warmth on first use. - Irritation: mild stinging or discomfort.

Serious or Rare Side Effects: - Allergic contact dermatitis: rash, swelling, or hives. - Severe skin swelling: edema beyond the treated area. - Urticaria: raised, itchy welts. - Photosensitivity: increased sunburn risk. - Secondary infection: signs of bacterial overgrowth. - Persistent discoloration: lasting hyperpigmentation.

Before using Irexime, consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: use only if the benefit outweighs potential risk. - Skin sensitivity: avoid application on broken, inflamed, or compromised skin. - Concurrent topical retinoids: may increase irritation; monitor closely. - Sun exposure: apply sunscreen and limit UV exposure while using the product. - Store at room temperature: keep in the original container, protect from moisture and light.

Irexime can interact with other topical agents; awareness helps minimise adverse outcomes.

Major Interactions (Avoid): - Other topical antibiotics (e.g., erythromycin): may reduce overall efficacy. - Systemic antibiotics for acne: could increase risk of bacterial resistance.

Moderate Interactions (Monitor Closely): - Topical retinoids: may heighten skin irritation. - Benzoyl peroxide‑containing cosmetics: can amplify dryness. - Photosensitising agents (e.g., tetracyclines): monitor for increased sun sensitivity. - Corticosteroid creams: may mask signs of infection.